[S18-02] Newborn screening for spinal muscular atrophy (SMA)

Last updated 27.03.2020

Project no.:
S18-02

Commission:
Commission awarded on 13.12.2018 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Non-Drug Interventions

Application field:
Prevention and screening, Children's and adolescents' health

27.03.2020

Spinal muscular atrophy (SMA): newborn screening promises a benefit

The earliest possible diagnosis and treatment of infantile SMA through newborn screening leads to better motor development and less need for permanent ventilatio...

Press release

Extract of the final report: Newborn screening for spinal muscular atrophy (SMA)

EN, PDF, 395 kB, PDF

published on Mar 27, 2020
Final report: Newborn screening for spinal muscular atrophy (SMA)

DE, PDF, 1 MB, PDF

published on Mar 27, 2020
Documentation of comments on the preliminary report: Newborn screening for spinal muscular atrophy (SMA)

DE, PDF, 2 MB, PDF

published on Mar 27, 2020
Preliminary report: Newborn screening for spinal muscular atrophy (SMA)

DE, PDF, 1 MB, PDF

published on Oct 30, 2019
Documentation of comments on the report plan: Newborn screening for spinal muscular atrophy (SMA)

DE, PDF, 368 kB, PDF

published on Oct 30, 2019
Report plan: Newborn screening for spinal muscular atrophy (SMA)

DE, PDF, 233 kB, PDF

published on Feb 27, 2019

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form